TRIALJECTORY
TrialJectory is an AI-based clinical trial-matching platform that uses self-reported clinical information to facilitate the clinical trial search and enrollment by cancer patients and their physicians. The Company partners with all sectors of the health industry to revolutionize the trial recruitment process, leading to reduced operational costs and expedited drugs' time to market.
TRIALJECTORY
Industry:
Communities Health Care Marketplace
Founded:
2017-12-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.trialjectory.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
27.72 M USD
Technology used in webpage:
Domain Not Resolving Mobile Non Scaleable Content Nginx Amazon Google Maps Person Schema Google Google Maps API Google Cloud Facebook Sharer
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Aulos Bioscience
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.
Mable
Mable is an online platform where people with disability, or those who are aging, can find and hire local care and support workers.
Imagia
Imagia is the indispensable AI healthcare partner for pharma, medical devices and clinical providers.
LunaPBC
LunaPBC is a healthcare company that transforms health data into health breakthroughs.
Sema4
Sema4 uses artificial intelligence and machine learning to analyze patient data to provide insights to transform the practice of medicine.
Current Advisors List
Current Employees Featured
Founder
Investors List
JAL Ventures
JAL Ventures investment in Series A - TrialJectory
Contour Venture Partners
Contour Venture Partners investment in Series A - TrialJectory
TIA Ventures
TIA Ventures investment in Series A - TrialJectory
Insight Partners
Insight Partners investment in Series A - TrialJectory
Rho Ventures
Rho Ventures investment in Series A - TrialJectory
Rho Ventures
Rho Ventures investment in Series A - TrialJectory
Contour Venture Partners
Contour Venture Partners investment in Series A - TrialJectory
TIA Ventures
TIA Ventures investment in Series A - TrialJectory
Connecticut Innovations
Connecticut Innovations investment in Series A - TrialJectory
Contour Venture Partners
Contour Venture Partners investment in Seed Round - TrialJectory
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-06 | Trialjectory Appoints Gregory T. Simpson as Chief Marketing Officer |
Official Site Inspections
http://www.trialjectory.com Semrush global rank: 1.53 M Semrush visits lastest month: 17.31 K
- Host name: ec2-18-209-211-122.compute-1.amazonaws.com
- IP address: 18.209.211.122
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "TrialJectory"
Leal Health - Crunchbase Company Profile & Funding
Leal Health, formerly known as Trialjectory, is a patient-first, AI-powered treatment decision support platform dedicated to improving cancer care. Working directly with patients, healthcare providers and pharmaceutical companies, …See details»
Trialjectory Raises $20 Million to Transform the Cancer Care Industry
NEW YORK, Feb. 7, 2022 /PRNewswire/ -- Trialjectory ("the Company"), the AI-powered decision-support platform for patients, health-care providers and pharma, announced today …See details»
Leal Health Launches First-of-its-Kind, Patient-Centric Program …
Mar 9, 2023 Leal Health, formerly known as Trialjectory, is a patient-first, AI-powered decision support platform dedicated to improving cancer treatment. Working directly with patients, …See details»
Israeli-US Startup Harnesses AI To Help Cancer Patients …
Oct 10, 2018 Trialjectory, with offices in Tel Aviv and New York, launched a unique service that connects cancer sufferers with clinical trials that are relevant specifically to them. ... Cancer patients often face long and difficult battles …See details»
Trialjectory Grows Pharmaceutical and Biotech Clinical Trial ...
Dec 5, 2022 Trialjectory is a patient-first, AI-powered decision support platform dedicated to improving cancer treatment. Working directly with patients, healthcare providers and …See details»
Trialjectory Raises $20 Million to Transform the Cancer Care Industry
NEW YORK, Feb. 7, 2022 /PRNewswire/ -- Trialjectory ("the Company"), the AI-powered decision-support platform for patients, health-care providers and pharma, announced today …See details»
Startup Helps Cancer Patients Find Clinical Trials, Offering ... - Forbes
Aug 17, 2021 New data from startup TrialJectory shows that most cancer patients want to be more involved in their treatment decisions since the pandemic and 93% are open to …See details»
Leal Health launches analytics platform to enhance recruitment to ...
Mar 9, 2023 Leal Health, formerly known as Trialjectory, rolled out its latest analytics program designed to help sponsors and sites develop patient-focused programs, improve recruitment …See details»
TrialJectory hauls in $20M series A money to boost AI health …
Feb 7, 2022 TrialJectory, a New York-based group that builds health support platforms, has hauled in $20 million in series A financing to bolster its AI-powered technology.. The funds will …See details»
Trialjectory on track to match 50K cancer patients with …
Nov 12, 2021 One company currently operating in this space is Trialjectory, founded in 2017. The startup matches cancer patients to clinical trials. In 2019, it only had about 2,000 members. In 2021, the ...See details»
Tzvia Bader on the TrialJectory Clinical Trial Tool - Cancer Network
Aug 25, 2020 A cancer survivor herself, Tzvia Bader, chief executive officer and co-founder of TrialJectory, also developed the platform to give pharmaceutical companies transparency into …See details»
MPN Research Foundation and Trialjectory Partner to Provide …
New York, N.Y., May 10, 2022 – MPN Research Foundation (MPNRF), a global organization driving research to find new and better treatments for myeloproliferative neoplasms (MPNs), a …See details»
TrialJectory - Democratization of Advanced Treatments - LinkedIn
May 15, 2019 TrialJectory is an AI-based marketplace that helps remove barriers between the patient community, oncologists and pharmaceutical companies. We help bridge the gap …See details»
A Guide To Cancer Trials - TIME
Nov 19, 2020 In 2020, cancer diagnoses will thrust nearly 2 million Americans into the often bewildering world of treatments and clinical trials. TrialJectory aims to help. The service uses …See details»
TrialJectory: The 100 Best Inventions of 2020 - TIME
Nov 19, 2020 I n 2020, cancer diagnoses will thrust nearly 2 million Americans into the often bewildering world of treatments and clinical trials. TrialJectory aims to help. The service uses …See details»
Trialjectory scores $20M to match cancer patients to clinical trials
Feb 7, 2022 "Trialjectory's model fosters a high-level of engagement with cancer patients. These trusted relationships, combined with the robust data and insight we provide pharma, [create] a …See details»
Trialjectory, foundation to connect cancer patients with trials
May 16, 2022 Trialjectory has announced a collaboration with the MPN Research Foundation, aimed at helping bring patients with rare blood cancers and studies in need of patients …See details»
TrialJectory Achieves 500 Percent Year-Over-Year Growth as …
Mar 9, 2021 TrialJectory is a patient-first digital health company with a mission to democratize access to advanced cancer treatment. Recognized by TIME as one of "The 100 Best …See details»
TrialJectory Product Demonstration - YouTube
Jun 24, 2020 Wondering how TrialJectory works? Watch the video to find out, and then go to https://www.trialjectory.com to discover advanced cancer treatment options pers...See details»